81 related articles for article (PubMed ID: 35028561)
1. Synthesis of low-molecular weight fucoidan derivatives and their binding abilities to SARS-CoV-2 spike proteins.
Koike T; Sugimoto A; Kosono S; Komaba S; Kanno Y; Kitamura T; Anzai I; Watanabe T; Takahashi D; Toshima K
RSC Med Chem; 2021 Dec; 12(12):2016-2021. PubMed ID: 35028561
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of fucoidan from Laminaria japonica against some pathogenic bacteria and SARS-CoV-2 depend on its large molecular weight.
Sun X; Ai C; Wen C; Peng H; Yang J; Cui Y; Song S
Int J Biol Macromol; 2023 Feb; 229():413-421. PubMed ID: 36587644
[TBL] [Abstract][Full Text] [Related]
3. Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives.
Tandon R; Sharp JS; Zhang F; Pomin VH; Ashpole NM; Mitra D; McCandless MG; Jin W; Liu H; Sharma P; Linhardt RJ
J Virol; 2021 Jan; 95(3):. PubMed ID: 33173010
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of factor IXa inhibition by antithrombin in the presence of unfractionated and low molecular weight heparins and fucoidan.
Mauray S; de Raucourt E; Talbot JC; Dachary-Prigent J; Jozefowicz M; Fischer AM
Biochim Biophys Acta; 1998 Sep; 1387(1-2):184-94. PubMed ID: 9748565
[TBL] [Abstract][Full Text] [Related]
5. Innovative Three-Step Microwave-Promoted Synthesis of
Santana-Romo F; Lagos CF; Duarte Y; Castillo F; Moglie Y; Maestro MA; Charbe N; Zacconi FC
Molecules; 2020 Jan; 25(3):. PubMed ID: 31979319
[TBL] [Abstract][Full Text] [Related]
6. In silico discovery of 3 novel quercetin derivatives against papain-like protease, spike protein, and 3C-like protease of SARS-CoV-2.
Bhattacharya K; Bordoloi R; Chanu NR; Kalita R; Sahariah BJ; Bhattacharjee A
J Genet Eng Biotechnol; 2022 Mar; 20(1):43. PubMed ID: 35262828
[TBL] [Abstract][Full Text] [Related]
7. Potential Anti-SARS-CoV-2 Activity of Pentosan Polysulfate and Mucopolysaccharide Polysulfate.
Zhang F; He P; Rodrigues AL; Jeske W; Tandon R; Bates JT; Bierdeman MA; Fareed J; Dordick J; Linhardt RJ
Pharmaceuticals (Basel); 2022 Feb; 15(2):. PubMed ID: 35215371
[TBL] [Abstract][Full Text] [Related]
8. Antithrombin activity of fucoidan. The interaction of fucoidan with heparin cofactor II, antithrombin III, and thrombin.
Church FC; Meade JB; Treanor RE; Whinna HC
J Biol Chem; 1989 Feb; 264(6):3618-23. PubMed ID: 2914965
[TBL] [Abstract][Full Text] [Related]
9. Systematic synthesis of low-molecular weight fucoidan derivatives and their effect on cancer cells.
Kasai A; Arafuka S; Koshiba N; Takahashi D; Toshima K
Org Biomol Chem; 2015 Nov; 13(42):10556-68. PubMed ID: 26340595
[TBL] [Abstract][Full Text] [Related]
10. Primary structure and anticoagulant activity of fucoidan from the sea cucumber Holothuria polii.
Mansour MB; Balti R; Yacoubi L; Ollivier V; Chaubet F; Maaroufi RM
Int J Biol Macromol; 2019 Jan; 121():1145-1153. PubMed ID: 30340002
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the heparin-binding site of the protein z-dependent protease inhibitor.
Yang L; Ding Q; Huang X; Olson ST; Rezaie AR
Biochemistry; 2012 May; 51(19):4078-85. PubMed ID: 22540147
[TBL] [Abstract][Full Text] [Related]
12. Pentosan Polysulfate Inhibits Attachment and Infection by SARS-CoV-2 In Vitro: Insights into Structural Requirements for Binding.
Bertini S; Alekseeva A; Elli S; Pagani I; Zanzoni S; Eisele G; Krishnan R; Maag KP; Reiter C; Lenhart D; Gruber R; Yates EA; Vicenzi E; Naggi A; Bisio A; Guerrini M
Thromb Haemost; 2022 Jun; 122(6):984-997. PubMed ID: 35322395
[TBL] [Abstract][Full Text] [Related]
13. Cinnamylindoline derivatives: synthesis and factor Xa (FXa) inhibitory activities.
Noguchi T; Tanaka N; Nishimata T; Goto R; Hayakawa M; Sugidachi A; Ogawa T; Asai F; Fujimoto K
Chem Pharm Bull (Tokyo); 2007 Oct; 55(10):1494-504. PubMed ID: 17917295
[TBL] [Abstract][Full Text] [Related]
14. Fibrinolytic and anticoagulant activities of highly sulfated fucoidan.
Soeda S; Sakaguchi S; Shimeno H; Nagamatsu A
Biochem Pharmacol; 1992 Apr; 43(8):1853-8. PubMed ID: 1533520
[TBL] [Abstract][Full Text] [Related]
15. Polysulfates Block SARS-CoV-2 Uptake through Electrostatic Interactions*.
Nie C; Pouyan P; Lauster D; Trimpert J; Kerkhoff Y; Szekeres GP; Wallert M; Block S; Sahoo AK; Dernedde J; Pagel K; Kaufer BB; Netz RR; Ballauff M; Haag R
Angew Chem Int Ed Engl; 2021 Jul; 60(29):15870-15878. PubMed ID: 33860605
[TBL] [Abstract][Full Text] [Related]
16. Pentasaccharide enhances the inactivation of factor Xa by antithrombin by promoting the assembly of a Michaelis-type intermediate complex. Demonstration by rapid kinetic, surface plasmon resonance, and competitive binding studies.
Rezaie AR
Biochemistry; 2006 Apr; 45(16):5324-9. PubMed ID: 16618121
[TBL] [Abstract][Full Text] [Related]
17. One-Pot Synthesis and Molecular Modeling Studies of New Bioactive Spiro-Oxindoles Based on Uracil Derivatives as SARS-CoV-2 Inhibitors Targeting RNA Polymerase and Spike Glycoprotein.
El-Kalyoubi SA; Ragab A; Abu Ali OA; Ammar YA; Seadawy MG; Ahmed A; Fayed EA
Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337173
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner.
Lavie M; Dubuisson J; Belouzard S
J Virol; 2022 Jul; 96(13):e0047422. PubMed ID: 35678602
[TBL] [Abstract][Full Text] [Related]
19. Venous antithrombotic and anticoagulant activities of a fucoïdan fraction.
Mauray S; Sternberg C; Theveniaux J; Millet J; Sinquin C; Tapon-Bretaudière J; Fischer AM
Thromb Haemost; 1995 Nov; 74(5):1280-5. PubMed ID: 8607110
[TBL] [Abstract][Full Text] [Related]
20. Indoline derivatives I: synthesis and factor Xa (FXa) inhibitory activities.
Noguchi T; Tanaka N; Nishimata T; Goto R; Hayakawa M; Sugidachi A; Ogawa T; Asai F; Matsui Y; Fujimoto K
Chem Pharm Bull (Tokyo); 2006 Feb; 54(2):163-74. PubMed ID: 16462058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
